-
2
-
-
75749105024
-
Daptomycin: From the mountain to the clinic, with essential help from Francis Tally, MD
-
Eisenstein BI, Oleson FB Jr, Baltz RH. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD. Clin Infect Dis. 2010;50:S10-5.
-
(2010)
Clin Infect Dis.
, vol.50
-
-
Eisenstein, B.I.1
Oleson Jr., F.B.2
Baltz, R.H.3
-
3
-
-
0037378761
-
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
-
Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 2003;47:1318-23.
-
(2003)
Antimicrob Agents Chemother.
, vol.47
, pp. 1318-1323
-
-
Dvorchik, B.H.1
Brazier, D.2
DeBruin, M.F.3
Arbeit, R.D.4
-
4
-
-
33749534709
-
Pharma-cokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
-
Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharma-cokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50:3245-9.
-
(2006)
Antimicrob Agents Chemother.
, vol.50
, pp. 3245-3249
-
-
Benvenuto, M.1
Benziger, D.P.2
Yankelev, S.3
Vigliani, G.4
-
5
-
-
36549005621
-
Daptomycin therapy for invasive Gram-positive bacterial infections in children
-
Ardura MI, Mejias A, Katz KS, Revell P, McCracken GH Jr, Sanchez PJ. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Pediatr Infect Dis J. 2007;26:1128-32.
-
(2007)
Pediatr Infect Dis J.
, vol.26
, pp. 1128-1132
-
-
Ardura, M.I.1
Mejias, A.2
Katz, K.S.3
Revell, P.4
Mccracken Jr., G.H.5
Sanchez, P.J.6
-
6
-
-
41649091233
-
Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections
-
Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J. 2008;27:330-4.
-
(2008)
Pediatr Infect Dis J.
, vol.27
, pp. 330-334
-
-
Abdel-Rahman, S.M.1
Benziger, D.P.2
Jacobs, R.F.3
Jafri, H.S.4
Hong, E.F.5
Kearns, G.L.6
-
7
-
-
79960619126
-
Single-dose pharmacokinetics and tolera-bility of daptomycin 8-10 mg/kg in children aged 2-6 years with suspected or proved Gram-Positive infections
-
Abdel-Rahman SM, Chandorkar G, Akins RL, Bradley JS, Jacobs RF, Donovan J, et al. Single-dose pharmacokinetics and tolera-bility of daptomycin 8-10 mg/kg in children aged 2-6 years with suspected or proved Gram-Positive infections. Pediatr Infect Dis J. 2011;30(8):712-4.
-
(2011)
Pediatr Infect Dis J.
, vol.30
, Issue.8
, pp. 712-714
-
-
Abdel-Rahman, S.M.1
Chandorkar, G.2
Akins, R.L.3
Bradley, J.S.4
Jacobs, R.F.5
Donovan, J.6
-
8
-
-
40349100430
-
Daptomycin use in infants: Report of two cases with peak and trough drug concentrations
-
Cohen-Wolkowiez M, Smith PB, Benjamin DK Jr, Fowler VG Jr, Wade KC. Daptomycin use in infants: report of two cases with peak and trough drug concentrations. J Perinatol. 2008;28:233-4.
-
(2008)
J Perinatol.
, vol.28
, pp. 233-234
-
-
Cohen-Wolkowiez, M.1
Smith, P.B.2
Benjamin Jr., D.K.3
Fowler Jr., V.G.4
Wade, K.C.5
-
9
-
-
77952936197
-
Daptomycin use in a neonate: Serum level monitoring and outcome
-
Sarafidis K, Iosifidis E, Gikas E, Tsivitanidou M, Drossou-Aga-kidou V, Roilides E. Daptomycin use in a neonate: serum level monitoring and outcome. Am J Perinatol. 2010;27:421-4.
-
(2010)
Am J Perinatol.
, vol.27
, pp. 421-424
-
-
Sarafidis, K.1
Iosifidis, E.2
Gikas, E.3
Tsivitanidou, M.4
Drossou-Aga-kidou, V.5
Roilides, E.6
-
10
-
-
67249136858
-
Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection
-
Chakraborty A, Roy S, Loeffler J, Chaves RL. Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection. J Antimicrob Chemother. 2009;64:151-8.
-
(2009)
J Antimicrob Chemother.
, vol.64
, pp. 151-158
-
-
Chakraborty, A.1
Roy, S.2
Loeffler, J.3
Chaves, R.L.4
-
11
-
-
79951637480
-
Tips and traps analyzing pediatric PK data
-
Anderson BJ, Holford NH. Tips and traps analyzing pediatric PK data. Paediatr Anaesth. 2011;21:222-37.
-
(2011)
Paediatr Anaesth.
, vol.21
, pp. 222-237
-
-
Anderson, B.J.1
Holford, N.H.2
-
12
-
-
0027311286
-
Aminoglycoside volume of distribution and illness severity in critically ill septic patients
-
Marik PE. Aminoglycoside volume of distribution and illness severity in critically ill septic patients. Anaesth Intensive Care. 1993;21:172-3.
-
(1993)
Anaesth Intensive Care.
, vol.21
, pp. 172-173
-
-
Marik, P.E.1
-
13
-
-
84855244376
-
Physiological changes in the critically ill patient with sepsis
-
Epub ahead of print
-
Hosein S, Udy AA, Lipman J. Physiological changes in the critically ill patient with sepsis. Curr Pharm Biotechnol [Epub ahead of print]. 2011.
-
(2011)
Curr Pharm Biotechnol
-
-
Hosein, S.1
Udy, A.A.2
Lipman, J.3
|